Vaccines, media: EU towards negotiations for a further 1.8 billion doses

2021-04-10T04:48:06.000Z

The European Commission will soon launch negotiations for 1.8 billion additional doses of the mRna-type vaccine against Covid-19. Bloomberg reported this, citing a source from the European executive. The choice of the type of drug is linked to the need to counteract the variants of the virus, he explained. Production should take place within the EU and delivery would be based on monthly commitments. The doses, the source said, will be intended for vaccinations scheduled for 2022 and 2023. The sera from Pfizer / BioNtech, Moderna and Curevac are of the mRna type.